The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM Severity

York University

Status and phase: Completed; Phase 1

Conditions: Type 2 Diabetes Mellitus

Treatments: Other: Placebo; Dietary Supplement: vitamin D3 and calcium

Study type: Interventional

Funder types: Other

Identifiers

NCT02464462

STU 2013-024 (Other Identifier)

220

Details and patient eligibility

About

The purpose of this study is to investigate the effect of vitamin D3 and calcium supplementation in attenuating type 2 diabetes mellitus outcomes in ethnic diverse, diabetic patiens.

Full description

Subjects of this study received a total of 1800 IU vitamin D3 and 720 mg of calcium per day for 3 years. The study was conducted in Toronto, Ontario, Canada.

Enrollment: 11 patients

Sex: Female

Ages: 40 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes mellitus
• Non-white, post menopausal female
• Have access to Community Health Center

Exclusion criteria

• neurodegenerative disease
• kideny disease
• gluten allergy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

11 participants in 2 patient groups, including a placebo group

CaD Group

Experimental group

Description:

This arm received total of 1800 IU of vitamin D3 and 720 mg of calcium

Treatment:

Dietary Supplement: vitamin D3 and calcium

Placebo Group

Placebo Comparator group

Description:

This arm received rice powder pills

Treatment:

Other: Placebo